Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
OTCMKTS · Delayed Price · Currency is USD
0.1700
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
SHPHF Revenue
Sihuan Pharmaceutical Holdings Group had revenue of 1.15B CNY in the half year ending June 30, 2025, with 8.57% growth. This brings the company's revenue in the last twelve months to 2.10B, up 19.55% year-over-year. In the year 2024, Sihuan Pharmaceutical Holdings Group had annual revenue of 1.90B with 2.18% growth.
Revenue (ttm)
2.10B CNY
Revenue Growth
+19.55%
P/S Ratio
6.62
Revenue / Employee
758.08K CNY
Employees
2,767
Market Cap
1.94B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.90B | 40.57M | 2.18% |
| Dec 31, 2023 | 1.86B | -320.65M | -14.70% |
| Dec 31, 2022 | 2.18B | -857.20M | -28.21% |
| Dec 31, 2021 | 3.04B | 574.17M | 23.30% |
| Dec 31, 2020 | 2.46B | -414.09M | -14.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Sihuan Pharmaceutical Holdings Group News
- 2 years ago - Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA - PRNewsWire